Literature DB >> 25246410

The VAGUS insight into psychosis scale--self-report and clinician-rated versions.

Philip Gerretsen1, Gary Remington2, Carol Borlido3, Lena Quilty4, Sabrina Hassan3, Gina Polsinelli3, Celine Teo3, Wanna Mar5, Regina Simon6, Mahesh Menon7, David D Pothier8, Shinichiro Nakajima9, Fernando Caravaggio10, David C Mamo11, Tarek K Rajji11, Benoit H Mulsant12, Vincenzo Deluca11, Rohan Ganguli2, Bruce G Pollock12, Ariel Graff-Guerrero13.   

Abstract

The aim of this study was to develop self-report and clinician-rated versions of an insight scale that would be easy to administer, sensitive to small changes, and inclusive of the core dimensions of clinical insight into psychosis. Ten-item self-report (VAGUS-SR) and five-item clinician-rated (VAGUS-CR) scales were designed to measure the dimensions of insight into psychosis and evaluated in 215 and 140 participants, respectively (www.vagusonline.com). Tests of reliability and validity were performed. Both the VAGUS-SR and VAGUS-CR showed good internal consistency and reliability. They demonstrated good convergent and discriminant validity. Both versions were strongly correlated with one another and with the Schedule for the Assessment of Insight and Birchwood Insight Scale. Exploratory factor analyses identified three possible latent components of insight. The VAGUS-CR and VAGUS-SR are valid, reliable and easy to administer. They are build on previous insight scales with separate clinician-rated and self-report versions. The VAGUS-SR exhibited a multidimensional factor structure. Using a 10-point Likert scale for each item, the VAGUS has the capacity to detect small, temporally sensitive changes in insight, which is essential for intervention studies with neurostimulation or rapidly acting medications.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Illness Awareness; Insight; Schizoaffective disorder; Schizophrenia; Symptom assessment

Mesh:

Year:  2014        PMID: 25246410      PMCID: PMC4470623          DOI: 10.1016/j.psychres.2014.08.005

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  23 in total

1.  Contralateral neglect induced by right posterior parietal rTMS in healthy subjects.

Authors:  B Fierro; F Brighina; M Oliveri; A Piazza; V La Bua; D Buffa; E Bisiach
Journal:  Neuroreport       Date:  2000-05-15       Impact factor: 1.837

2.  SPSS and SAS programs for determining the number of components using parallel analysis and velicer's MAP test.

Authors:  B P O'Connor
Journal:  Behav Res Methods Instrum Comput       Date:  2000-08

3.  rTMS of the unaffected hemisphere transiently reduces contralesional visuospatial hemineglect.

Authors:  M Oliveri; E Bisiach; F Brighina; A Piazza; V La Bua; D Buffa; B Fierro
Journal:  Neurology       Date:  2001-10-09       Impact factor: 9.910

4.  The assessment of insight in psychosis.

Authors:  A David; A Buchanan; A Reed; O Almeida
Journal:  Br J Psychiatry       Date:  1992-11       Impact factor: 9.319

Review 5.  Insight in schizophrenia: a meta-analysis.

Authors:  Alisa R Mintz; Keith S Dobson; David M Romney
Journal:  Schizophr Res       Date:  2003-05-01       Impact factor: 4.939

6.  Insight and symptom change in schizophrenia and other disorders.

Authors:  M A Weiler; M H Fleisher; D McArthur-Campbell
Journal:  Schizophr Res       Date:  2000-09-29       Impact factor: 4.939

7.  Self-Appraisal of Illness Questionnaire (SAIQ): relationship to researcher-rated insight and neuropsychological function in schizophrenia.

Authors:  K A Marks; P S Fastenau; P H Lysaker; G R Bond
Journal:  Schizophr Res       Date:  2000-10-27       Impact factor: 4.939

8.  Reappraising insight in psychosis. Multi-scale longitudinal study.

Authors:  M J Cuesta; V Peralta; A Zarzuela
Journal:  Br J Psychiatry       Date:  2000-09       Impact factor: 9.319

9.  Insight in schizophrenia. Its relationship to acute psychopathology.

Authors:  J P McEvoy; L J Apperson; P S Appelbaum; P Ortlip; J Brecosky; K Hammill; J L Geller; L Roth
Journal:  J Nerv Ment Dis       Date:  1989-01       Impact factor: 2.254

10.  A new instrument for measuring insight: the Beck Cognitive Insight Scale.

Authors:  Aaron T Beck; Edward Baruch; Jordan M Balter; Robert A Steer; Debbie M Warman
Journal:  Schizophr Res       Date:  2004-06-01       Impact factor: 4.939

View more
  10 in total

1.  Vestibular stimulation improves insight into illness in schizophrenia spectrum disorders.

Authors:  Philip Gerretsen; David D Pothier; Carolyn Falls; Maxine Armstrong; Thushanthi Balakumar; Hiroyuki Uchida; David C Mamo; Bruce G Pollock; Ariel Graff-Guerrero
Journal:  Psychiatry Res       Date:  2017-02-13       Impact factor: 3.222

2.  A Measure of Illness Awareness in Individuals With Nicotine Dependence-Nicotine Use Awareness and Insight Scale.

Authors:  Julia Kim; Yasaman Kambari; Anmol Taggar; Lena C Quilty; Peter Selby; Fernando Caravaggio; Fumihiko Ueno; Jianmeng Song; Bruce G Pollock; Ariel Graff-Guerrero; Philip Gerretsen
Journal:  Nicotine Tob Res       Date:  2022-03-01       Impact factor: 4.244

3.  BASIS: The blood pressure awareness and insight scale.

Authors:  Philip Gerretsen; Julia Kim; Parita Shah; Lena Quilty; Thushanthi Balakumar; Fernando Caravaggio; Eric Plitman; Jun Ku Chung; Yusuke Iwata; Bruce G Pollock; Satya Dash; Sanjeev Sockalingam; Ariel Graff-Guerrero
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-03-10       Impact factor: 3.738

4.  Stronger default mode network connectivity is associated with poorer clinical insight in youth at ultra high-risk for psychotic disorders.

Authors:  Sarah V Clark; Vijay A Mittal; Jessica A Bernard; Aral Ahmadi; Tricia Z King; Jessica A Turner
Journal:  Schizophr Res       Date:  2017-07-05       Impact factor: 4.939

5.  A Measure to Assess Illness Awareness in Problem Gambling: Gambling Awareness and Insight Scale (GAS).

Authors:  Julia Kim; Aron Amaev; Lena C Quilty; Peter Selby; Parita Shah; Fernando Caravaggio; Fumihiko Ueno; Bruce G Pollock; Ariel Graff-Guerrero; Philip Gerretsen
Journal:  J Gambl Stud       Date:  2021-06-24

6.  Drug Attitude, Insight, and Patient's Knowledge About Prescribed Antipsychotics in Schizophrenia: A Cross-Sectional Survey.

Authors:  Nobuhiro Nagai; Hideaki Tani; Kazunari Yoshida; Philip Gerretsen; Takefumi Suzuki; Saeko Ikai-Tani; Masaru Mimura; Hiroyuki Uchida
Journal:  Neuropsychiatr Dis Treat       Date:  2020-03-23       Impact factor: 2.570

Review 7.  Improvement of Insight with Non-Invasive Brain Stimulation in Patients with Schizophrenia: A Systematic Review.

Authors:  Martin Blay; Ondine Adam; Rémy Bation; Filipe Galvao; Jérôme Brunelin; Marine Mondino
Journal:  J Clin Med       Date:  2021-12-22       Impact factor: 4.241

8.  Dynamics between insight and medication adherence in first-episode psychosis: Study of 3-year trajectories.

Authors:  Julien Elowe; Julie Ramain; Alessandra Solida; Philippe Conus; Philippe Golay
Journal:  Eur Psychiatry       Date:  2022-08-15       Impact factor: 7.156

9.  OASIS: The Obesity Awareness and Insight Scale.

Authors:  Philip Gerretsen; Julia Kim; Parita Shah; Lena Quilty; Thushanthi Balakumar; Fernando Caravaggio; Eric Plitman; Jun Ku Chung; Yusuke Iwata; Bruce G Pollock; Satya Dash; Sanjeev Sockalingam; Ariel Graff-Guerrero
Journal:  Obes Med       Date:  2018-02-12

10.  Gap between patients with schizophrenia and their psychiatrists on the needs to psychopharmacological treatment: A cross-sectional study.

Authors:  Kie Takahashi; Ryoko Yamazawa; Takefumi Suzuki; Masaru Mimura; Hiroyuki Uchida
Journal:  Neuropsychopharmacol Rep       Date:  2020-06-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.